Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-05 5:23 pm Purchase |
2022-07-26 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lind Global Fund II LP | 10,185 9.900% |
8,979 (+744.27%) |
Filing History |
| 2022-07-22 5:00 pm Purchase |
2022-07-19 | 13G | Performance Shipping Inc. PSHG |
Lind Global Fund II LP | 93,333 5.100% |
93,333 (New Position) |
Filing History |
| 2022-07-13 5:00 pm Purchase |
2022-07-06 | 13G | Staffing 360 Solutions, Inc. STAF |
Lind Global Fund II LP | 11,777 5.400% |
11,777 (New Position) |
Filing History |
| 2022-07-12 5:00 pm Purchase |
2022-07-06 | 13G | Agile Therapeutics, Inc. AGRX |
Lind Global Fund II LP | 65,004 9.900% |
65,004 (New Position) |
Filing History |
| 2022-06-08 5:00 pm Purchase |
2022-06-07 | 13G | Energy Focus, Inc. EFOI |
Lind Global Fund II LP | 114,609 9.900% |
114,609 (New Position) |
Filing History |
| 2022-05-23 5:00 pm Purchase |
2022-05-17 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Lind Global Fund II LP | 36,150 9.900% |
36,150 (New Position) |
Filing History |
| 2022-04-29 4:31 pm Purchase |
2022-04-26 | 13G | Salarius Pharmaceuticals, Inc. SLRX |
Lind Global Fund II LP | 14,849 5.300% |
14,849 (New Position) |
Filing History |
| 2022-04-20 5:11 pm Purchase |
2022-04-14 | 13G | Kintara Therapeutics, Inc. KTRA |
Lind Global Fund II LP | 2,156 5.800% |
2,156 (New Position) |
Filing History |
| 2022-02-23 5:00 pm Purchase |
2022-02-15 | 13G | CEA Industries Inc. CEAD |
Lind Global Fund II LP | 33,333 5.400% |
33,333 (New Position) |
Filing History |
| 2022-02-11 5:09 pm Sale |
2021-12-31 | 13G | Superior Drilling Products, Inc. SDPI |
Lind Global Fund II LP | 908,643 3.200% |
-830,488 (-47.75%) |
Filing History |
| 2022-02-11 5:08 pm Sale |
2021-12-31 | 13G | PEDEVCO Corp. PED |
Lind Global Fund II LP | 0 0.000% |
-4,458,600 (Position Closed) |
Filing History |
| 2022-02-11 5:07 pm Purchase |
2021-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lind Global Fund II LP | 1,206 3.300% |
1,206 (New Position) |
Filing History |
| 2022-02-11 5:00 pm Purchase |
2022-01-27 | 13G | ReWalk Robotics Ltd. LFWD |
Lind Global Fund II LP | 1,034,019 11.400% |
564,766 (+120.35%) |
Filing History |
| 2022-01-21 5:01 pm Purchase |
2022-01-20 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Lind Global Fund II LP | 5,150 9.900% |
5,150 (New Position) |
Filing History |
| 2021-10-19 5:15 pm Purchase |
2021-10-19 | 13G | Superior Drilling Products, Inc. SDPI |
Lind Global Fund II LP | 1,739,131 6.300% |
1,739,131 (New Position) |
Filing History |
| 2021-10-06 5:11 pm Purchase |
2021-10-06 | 13G | PEDEVCO Corp. PED |
Lind Global Fund II LP | 4,458,600 5.300% |
4,458,600 (New Position) |
Filing History |
| 2021-10-04 5:11 pm Purchase |
2021-09-29 | 13G | ReWalk Robotics Ltd. LFWD |
Lind Global Fund II LP | 469,253 5.300% |
469,253 (New Position) |
Filing History |
| 2021-08-20 4:45 pm Purchase |
2021-08-11 | 13G | EyeGate Pharmaceuticals, Inc. EYEG |
Lind Global Fund II LP | 1,302,933 9.900% |
1,302,933 (New Position) |
Filing History |